![EP2295083A1 - Pharmaceutical composition comprising active agents metformin and sitagliptin or vildagliptin - Google Patents EP2295083A1 - Pharmaceutical composition comprising active agents metformin and sitagliptin or vildagliptin - Google Patents](https://patentimages.storage.googleapis.com/05/36/56/611513ed40cb0c/imgb0001.png)
EP2295083A1 - Pharmaceutical composition comprising active agents metformin and sitagliptin or vildagliptin - Google Patents
![Insulin: Tablette statt Spritze? - Blutzucker-regulierendes Hormon könnte künftig oral verabreicht werden - scinexx.de Insulin: Tablette statt Spritze? - Blutzucker-regulierendes Hormon könnte künftig oral verabreicht werden - scinexx.de](https://www.scinexx.de/wp-content/uploads/0/1/01-36681-insulinpille1.jpg)
Insulin: Tablette statt Spritze? - Blutzucker-regulierendes Hormon könnte künftig oral verabreicht werden - scinexx.de
Package leaflet: Information for the patient Sitagliptin/Metformin Clonmel 50 mg/850 mg film-coated tablets Sitagliptin/Metformi
![New International Clinical Trial To Evaluate Allopurinol for Diabetic Nephropathy in Type 1 Diabetics New International Clinical Trial To Evaluate Allopurinol for Diabetic Nephropathy in Type 1 Diabetics](https://diabetesnewsjournal.com/wp-content/uploads/2015/09/shutterstock_208912816.jpg)